ARCHIVES

In Brief: James Downing named CEO of St. Jude

This article is from The Cancer Letter archive.

Vol. 40 No. 26 | June 27, 2014

Download PDF Visit The Full Archive

Related Articles

FDA Approves Novartis Drug Zometa For Multiple Myeloma And Bone Mets.

March 1, 2002

Progress Toward Year 2000 Goal Slow, But NCAB Says It’s Too Early, Only Data Up To ’87 Available

January 12, 1990

In Brief: ACS Appoints Directors For Government Relations And Grassroots Development

April 25, 1997

USC Cancer Center Plans Expansion, Gets New Name

January 27, 1989

In Brief: Alfred Ketcham Is New SSO President; Meyskens Receives NCI Year 2000 Award; Colman Honored

August 10, 1990

In congress: Senate Committee Approves 7.5 Percent Increase for NIH

July 25, 1997